American Century Companies’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.2M Buy
866,243
+137,913
+19% +$5.14M 0.02% 989
2026
Q1
$29.3M Sell
728,330
-4,369
-0.6% -$188K 0.02% 998
2025
Q4
$37.1M Buy
732,699
+24,276
+3% +$862K 0.02% 864
2025
Q3
$20.6M Sell
708,423
-6,005
-0.8% -$139K 0.01% 1135
2025
Q2
$16.8M Buy
714,428
+336,978
+89% +$7.58M 0.01% 1169
2025
Q1
$9.07M Sell
377,450
-51,490
-12% -$1.65M 0.01% 1356
2024
Q4
$18.1M Buy
428,940
+42,526
+11% +$1.88M 0.01% 1096
2024
Q3
$17.1M Sell
386,414
-966
-0.2% -$36.7K 0.01% 1093
2024
Q2
$14M Buy
+387,380
New +$15.4M 0.01% 1103

Other funds holding VERA

American Century Companies's VERA Position: Q2 2026 in Review

American Century Companies increased its Vera Therapeutics (VERA) stake by 19% in Q2 2026, buying an estimated $5.14M and bringing the position to 866,243 shares worth $37.2M. The position accounts for 0.02% of the portfolio, ranked #989.

American Century Companies first reported a position in VERA in Q2 2024 and has held it in 9 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • American Century Companies held 866,243 shares of Vera Therapeutics worth $37.2M as of Q2 2026.
  • American Century Companies bought 137,913 Vera Therapeutics shares in Q2 2026, an estimated $5.14M.
  • Vera Therapeutics made up 0.02% of American Century Companies's portfolio in Q2 2026, its #989 holding.
  • American Century Companies first reported a position in Vera Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.